Premium Company Profile Gedeon Richter

Gedeon Richter's main focus is to develop and commercialize products for the treatment of diseases in the areas of central nervous, cardio vascular, gynaecological and muscle related diseases. The company has a strong franchise in generic drugs throughout the CEE and CIS regions as well as in steroids in the US.

Report Highlights
Gedeon Richter derives its revenues mainly from production and marketing of its own pharmaceutical products. In addition, the company recognizes revenues from royalties and collaboration revenues related to license agreements with other pharmaceutical companies Gedeon Richter's clinical development initiatives currently focus on 16 product candidates, which includes RGH-188 and RGH-896 for the treatment of Schizophrenia and chronic pain respectively. Both the product candidates are in the Phase II trials The company's total revenues increased at a CAGR of 15% during 2002-2006, from $586 million to $1,022 million. The company's major contributor to revenue growth during 2002-2006 was product sales which increased at an absolute growth of +$434 million during the period
[Studien Infos ausblenden]

Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 9
Locations and Subsidiaries 11
Company Financials 12
P&L 12
Balance Sheet 14
Cash Flow 14
Business Segment Performance 15
Geographic Segment Performance 15
Products & Services 17
Marketed Products 17
Pipeline Products 31
Historical Product Sales 32
AC Forecast Product Sales 34
Competitors and Strategic Business Relationships 36
Key Competitors 36
Key Suppliers 36
Key Clients 36
Shareholding Structure 37
Strategy 38
Company View 38
Corporate Strategy 39
SWOT Analysis 41
Overview 41
Strengths 42
Weaknesses 44
Opportunities 45
Threats 46
Value Chain Analysis 48
Overview 48
Discovery and Product Development 48
Manufacturing 49
Sales 49
Scorecard 50
Overview 50
Scorecard Analysis 51
Key Employees 52
List of Key Employees 52
Key Employee Biographies 53
Financial and Operational Overview 58
Financial and Operational Overview 58
Key Industry Specific Ratios 61
APPENDIX 62
Ask the analyst 62
Datamonitor consulting 62
Disclaimer 62
[Inhaltsverzeichnis ausblenden]

Table 1: Gedeon Richter - Key Facts 6
Table 2: Gedeon Richter – Locations and Subsidiaries 11
Table 3: Gedeon Richter - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12
Table 4: Gedeon Richter - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 14
Table 5: Gedeon Richter – Balance Sheet, 2002-2006 ($ Mn) 14
Table 6: Gedeon Richter – Cash Flow, 2002-2006 ($ Mn) 14
Table 7: Gedeon Richter - Revenue Breakdown, 2002-2006 ($ Mn) 15
Table 8: Gedeon Richter - Geographic Breakdown, 2002-2006 ($ Mn) 16
Table 9: Gedeon Richter - Marketed Products 17
Table 10: Gedeon Richter - Collaboration Pipeline Products 31
Table 11: Gedeon Richter - Historical Product Sales, 2002-2006 ($ Mn) 32
Table 12: Gedeon Richter - Forecast Sales, 2006-2010 ($ Mn) 34
Table 13: Gedeon Richter – Key Suppliers 36
Table 14: Gedeon Richter - Key Shareholders 37
Table 15: Gedeon Richter - SWOT Analysis Summary 41
Table 17: Gedeon Richter - Scorecard 50
Table 18: Gedeon Richter – Key Employees 52
Table 19: Gedeon Richter – Financial and Operational Overview 58
Table 20: Gedeon Richter - Key Industry Specific Ratios 61

Figure 1: Gedeon Richter - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
Figure 2: Gedeon Richter - Key Strategic Products Revenues, 2002-2006 ($ Mn) 32
Figure 3: Gedeon Richter - Key Strategic Products Revenues, 2006-2010 ($ Mn) 35
[Tabellenverzeichnis ausblenden]